Open-label extension study of flibanserin in women with hypoactive sexual desire disorder

Articles

Open-label extension study of flibanserin in women with hypoactive sexual desire disorderIntroduction: Hypoactive Sexual Desire Disorder (HSDD) is a common form of Female Sexual Dysfunction characterized by low sexual desire that causes distress or interpersonal difficulty. Aim: This 52-week open-label extension study aimed to assess the safety and tolerability of flibanserin, a postsynaptic 5-HT(1A) agonist/5-HT(2A)…

Efficacy of flibanserin in women with hypoactive sexual desire disorder: Results from the BEGONIA trial

Articles

Efficacy of flibanserin in women with hypoactive sexual desire disorder: Results from the BEGONIA trialIntroduction: Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire that causes marked distress or interpersonal difficulty. Aim: The aim of this study was to assess the efficacy and safety of the 5-HT1A agonist/5-HT2A antagonist flibanserin in premenopausal women…